• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素可抑制性醛固酮增多症中的11β-羟化酶活性:对原发性高血压的启示?

11 beta-Hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: lessons for essential hypertension?

作者信息

Connell J M, Jamieson A J, Davies E, Ingram M, Soro A, Fraser R

机构信息

Medical Research Council Blood Pressure Group, Therapeutics Western Infirmary, Glasgow, Scotland.

出版信息

Endocr Res. 1996 Nov;22(4):691-700. doi: 10.1080/07435809609043764.

DOI:10.1080/07435809609043764
PMID:8969929
Abstract

Corticosteroid 11 beta-hydroxylation is catalysed by 11 beta-hydroxylase and aldosterone synthase. Using plasma steroid ratios, the level of this process in patients with glucocorticoid-suppressible hyperaldosteronism (GSH) was compared with that in unaffected control subjects and in patients with Conn's syndrome. Based on both 11-deoxycortisol:cortisol (S:F) and 11-deoxycorticosterone:corticosterone (DOC:B) ratios, patients with GSH showed impaired resting 11 beta-hydroxylase activity. In GSH, but not in the other groups, the S:F ratio was significantly correlated with basal plasma aldosterone concentration. ACTH infusion increased the S:F ratio in all these patient groups, suggesting a common partial deficiency. The results also indicate that 11 beta-hydroxylation may be rate-limiting in normal subjects. In control subjects and patients with Conn's syndrome, the DOC:B ratio was not affected by ACTH. However, in GSH patients, this ratio fell markedly, indicating an increased efficiency of 11 beta-hydroxylation of DOC (but not S). This may be due to the activation by ACTH of the zona fasciculata chimaeric aldosterone synthase characteristic of this disease. Plasma aldosterone, corticosterone and DOC concentrations, appeared to be more sensitive to ACTH in GSH than the other groups. The defect in 11 beta-hydroxylation in GSH accounts for the increased levels of DOC reported in the condition, and may contribute to the phenotypic variability.

摘要

皮质类固醇11β-羟化由11β-羟化酶和醛固酮合酶催化。利用血浆类固醇比率,将糖皮质激素可抑制性醛固酮增多症(GSH)患者的这一过程水平与未受影响的对照受试者及原发性醛固酮增多症患者进行比较。基于11-脱氧皮质醇:皮质醇(S:F)和11-脱氧皮质酮:皮质酮(DOC:B)比率,GSH患者显示静息时11β-羟化酶活性受损。在GSH患者中,而非其他组中,S:F比率与基础血浆醛固酮浓度显著相关。促肾上腺皮质激素(ACTH)输注使所有这些患者组的S:F比率升高,提示存在共同的部分缺陷。结果还表明,11β-羟化在正常受试者中可能是限速步骤。在对照受试者和原发性醛固酮增多症患者中,DOC:B比率不受ACTH影响。然而,在GSH患者中,该比率显著下降,表明DOC(而非S)的11β-羟化效率提高。这可能是由于ACTH激活了该病特有的束状带嵌合醛固酮合酶。与其他组相比,GSH患者的血浆醛固酮、皮质酮和DOC浓度似乎对ACTH更敏感。GSH中11β-羟化缺陷解释了该病症中报道的DOC水平升高,并可能导致表型变异性。

相似文献

1
11 beta-Hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: lessons for essential hypertension?糖皮质激素可抑制性醛固酮增多症中的11β-羟化酶活性:对原发性高血压的启示?
Endocr Res. 1996 Nov;22(4):691-700. doi: 10.1080/07435809609043764.
2
Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism.糖皮质激素可抑制性醛固酮增多症中11β-羟化酶活性的改变。
J Clin Endocrinol Metab. 1996 Jun;81(6):2298-302. doi: 10.1210/jcem.81.6.8964867.
3
An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects.醛固酮合成酶基因(CYP11B2)变异对正常人类受试者皮质类固醇对促肾上腺皮质激素反应的影响。
Clin Endocrinol (Oxf). 2001 Jun;54(6):813-7. doi: 10.1046/j.1365-2265.2001.01264.x.
4
Abnormality of aldosterone and cortisol late pathways in glucocorticoid-remediable aldosteronism.糖皮质激素可治性醛固酮增多症中醛固酮和皮质醇晚期途径的异常。
J Clin Endocrinol Metab. 1994 Sep;79(3):772-4. doi: 10.1210/jcem.79.3.8077359.
5
Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.用血浆皮质酮、脱氧皮质酮、皮质醇和脱氧皮质醇评估11β-羟化酶活性:促肾上腺皮质激素和血管紧张素的作用
J Clin Endocrinol Metab. 1977 Mar;44(3):560-8. doi: 10.1210/jcem-44-3-560.
6
Response of several adrenal steroids to ACTH stimulation in essential hypertension.原发性高血压患者几种肾上腺类固醇对促肾上腺皮质激素刺激的反应。
J Clin Endocrinol Metab. 1977 Feb;44(2):264-72. doi: 10.1210/jcem-44-2-264.
7
Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.糖皮质激素可抑制性醛固酮增多症中肾上腺类固醇对促肾上腺皮质激素的反应。
Hypertension. 1984 Jul-Aug;6(4):563-7. doi: 10.1161/01.hyp.6.4.563.
8
Etomidate: a selective adrenocortical 11 beta-hydroxylase inhibitor.依托咪酯:一种选择性肾上腺皮质11β-羟化酶抑制剂。
Klin Wochenschr. 1984 Nov 2;62(21):1011-3. doi: 10.1007/BF01711722.
9
Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension.肾上腺11β-羟化酶部分缺乏。原发性高血压的一个可能病因。
Hypertension. 1985 Mar-Apr;7(2):204-10. doi: 10.1161/01.hyp.7.2.204.
10
Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.糖皮质激素可治性醛固酮增多症家族中不同表型的共存。
J Hum Hypertens. 2004 Jan;18(1):47-51. doi: 10.1038/sj.jhh.1001636.

引用本文的文献

1
Hypertension and the expanding role of aldosterone.高血压与醛固酮作用的扩展
Curr Hypertens Rep. 2006 Jun;8(3):255-61. doi: 10.1007/s11906-006-0059-y.
2
Mechanisms of hypertension: the expanding role of aldosterone.高血压的发病机制:醛固酮的作用不断扩大。
J Am Soc Nephrol. 2004 Aug;15(8):1993-2001. doi: 10.1097/01.ASN.0000132473.50966.14.
3
The epithelial sodium channel in hypertension.
Curr Hypertens Rep. 1999 Apr-May;1(2):158-63. doi: 10.1007/s11906-999-0013-x.